Profil
Stephen R.
Brady is President, Chief Executive Officer & Director at Claris Biotherapeutics, Inc. starting in 2026.
He is Director at Biotechnology Innovation Organization since 2022.
He is Independent Director at Atreca, Inc. since 2021.
Formerly, he was President, Chief Executive Officer & Director at Tempest Therapeutics, Inc. from 2023 to 2026.
He was Director-Corporate Development at Proteolix, Inc. in 2009.
He was Vice President at Lazard Frères & Co. LLC from 2000 to 2013.
He was Senior Corporate Counsel at Lexicon Pharmaceuticals, Inc. from 2001 to 2007.
He was President & Chief Operating Officer at TempestTx, Inc. from 2019 to 2021.
He was Associate at Morrison & Foerster LLP from 1996 to 2000.
He was Executive Vice President-Strategy & Finance at Immune Design Corp.
from 2015 to 2019.
He was VP-Corporate Development, Strategy & Operations at Sagimet Biosciences, Inc. from 2010 to 2011.
Education includes undergraduate degree from the University of Oregon, graduate degrees from the University of the Pacific and New York University School of Law.
Postes actifs de Stephen Brady
| Sociétés | Poste | Début |
|---|---|---|
| ATRECA, INC. | Directeur/Membre du Conseil | 14/07/2021 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 01/01/2022 |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs | Directeur Général | 28/07/2026 |
Anciens postes connus de Stephen Brady
| Sociétés | Poste | Fin |
|---|---|---|
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | President | 01/06/2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 02/04/2019 |
| SAGIMET BIOSCIENCES INC. | Directeur des opérations | 11/02/2011 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Conseiller Juridique Général | 25/03/2009 |
| LEXICON PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2007 |
Formation de Stephen Brady
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Lazard Frères & Co. LLC
Lazard Frères & Co. LLC Investment ManagersFinance Provides corporate advisory, capital market, and asset management services | Finance |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Atreca, Inc.
Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs | Health Technology |
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
















